  |
 | Up a level |
Nathan, Paul D. and Robert, Caroline and Grob, Jean Jacques and Stroyakovskiy, Daniil and Karaszewska, Boguslawa and Hauschild, Axel and Levchenko, Eugeny and Sileni, Vanna Chiarion and Schachter, Jacob and Garbe, Claus and Bondarenko, Igor and Davies, Michael A. and Ribas, Antoni and Flaherty, Keith and Burgess, Paul and Tan, Monique and Gasal, Eduard and Schadendorf, Dirk and Georgina V. (2019) Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma. Journal of Clinical Oncology, 37 (15supp). p. 9507. ISSN 1527-7755 (online, version of record) and 0732-183X (print)
Schadendorf, Dirk and Di Giacomo, Anna Maria and Demidov, Lev and Merelli, Barbara and Bondarenko, Igor and Ascierto, Paolo A. and Herbert, Christopher and Mackiewicz, Andrzej and Rutkowski, Piotr and Guminski, Alexander and Goodman, Grant R. and Simmons, Brian and Ye, Chenglin and Hong, Agnes and Lewis, Karl and the BRIM8 Investigators (2019) Health-related quality of life in patients with fully resected BRAFV600 mutation–positive melanoma receiving adjuvant vemurafenib. European Journal of Cancer, V.123. pp. 155-161. ISSN 0959-8049
